Of note, it has been reported that ERK5 is dispensable for proliferation of colorectal cancer cells carrying KRAS/BRAF mutations [38], suggesting that genetic mutational background must be considered to establish the exact role of ERK5 in proliferation of different cancer types. This evidence concerns the gene KRAS and colorectal cancer.